Investigational Site Number :2680007

Tbilisi 0159

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Kidney Diseases, Crohn's Disease, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. — Recruiting now
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early